Showing posts with label parasitic diseases. Show all posts
Showing posts with label parasitic diseases. Show all posts

Sunday, April 3, 2011

AMEDEO Parasitic Diseases: Your April 2011 Journal Article Update


1. AMEDEO Parasitic Diseases

2011-04-04

2. The 2011 Short Guide to Hepatitis C (128 pages, PDF + ePub)

The book is available for download at www.FlyingPublisher.com .

If you are an expert in your field, please consider publishing a Flying Publisher Guide and reach out to a worldwide audience:

If not, start recommending your colleagues:


3. Free Books + 2000 Free Journals


Best regards,

Bernd Sebastian Kamps


________________ ** New articles **  _________________


1. FRIESEN J, Borrmann S, Matuschewski K.
Induction of Anti-Malaria Immunity by Pyrimethamine Prophylaxis during Exposure to Sporozoites is Curtailed by Parasite Resistance.
Antimicrob Agents Chemother. 2011.
ABSTRACT available


2. ZHU J, Krishnegowda G, Li G, Gowda DC, et al.
Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum are mainly mediated through the recognition of TLR2/TLR1.
Exp Parasitol. 2011.
ABSTRACT available


3. AYUK MA, Suttiprapa S, Rinaldi G, Mann VH, et al.
Schistosoma mansoni U6 gene promoter-driven short hairpin RNA induces RNA interference in human fibrosarcoma cells and schistosomules.
Int J Parasitol. 2011.
ABSTRACT available


4. VINCE JE, Tull D, Landfear S, McConville MJ, et al.
Lysosomal degradation of Leishmania hexose and inositol transporters is regulated in a stage-, nutrient- and ubiquitin-dependent manner.
Int J Parasitol. 2011.
ABSTRACT available


5. AWASTHI G, Prasad GB, Das A.
Population genetic analyses of Plasmodium falciparum chloroquine receptor transpoter gene haplotypes reveal an evolutionary history of chloroquine-resistant malaria in India.
Int J Parasitol. 2011.
ABSTRACT available


6. ARCHIE EA, Ezenwa VO.
Population genetic structure and history of a generalist parasite infecting multiple sympatric host species.
Int J Parasitol. 2011;41:89-98.
ABSTRACT available


7. SALWATI E, Minigo G, Woodberry T, Piera KA, et al.
Differential Cellular Recognition of Antigens During Acute Plasmodium falciparum and Plasmodium vivax Malaria.
J Infect Dis. 2011;203:1192-9.
ABSTRACT available


8. LEE EF, Clarke OB, Evangelista M, Feng Z, et al.
Discovery and molecular characterization of a Bcl-2-regulated cell death pathway in schistosomes.
Proc Natl Acad Sci U S A. 2011.
ABSTRACT available


_____________________ ** End ** ______________________



We have screened the following journals for you:
Acta Cytol
Am J Gastroenterol
Am J Trop Med Hyg
Antimicrob Agents Chemother
Br J Dermatol
Br J Haematol
Clin Infect Dis
Epidemiol Infect
Eur J Immunol
Exp Parasitol
Infect Immun
Int J Parasitol
J Clin Microbiol
J Eukaryot Microbiol
J Exp Med
J Immunol
J Infect Dis
J Parasitol
JAMA
Lancet
N Engl J Med
Nat Med
Nature
Neurology
Parasite Immunol
Parasitology
Proc Natl Acad Sci U S A
Science
Trop Med Int Health

_________________________________________________________

Sunday, January 16, 2011

Parasitic Diseases: Latest Research January 2011

AMEDEO Parasitic Diseases


2011-01-17


________________ ** New articles **  _________________


1. KARL S, Davis TM, St Pierre TG.
Quantification of Plasmodium falciparum Gametocytes by Magnetic Fractionation.
Am J Trop Med Hyg. 2011;84:158-60.
ABSTRACT available


2. RAMANATHAN R, Talaat KR, Fedorko DP, Mahanty S, et al.
A Species-Specific Approach to the Use of Non-Antimony Treatments for Cutaneous
Leishmaniasis.
Am J Trop Med Hyg. 2011;84:109-117.
ABSTRACT available


3. PANDEY BD, Pun SB, Kaneko O, Pandey K, et al.
Expansion of visceral leishmaniasis to the Western hilly part of Nepal.
Am J Trop Med Hyg. 2011;84:107-8.
ABSTRACT available


4. CANAVATE C, Herrero M, Nieto J, Cruz I, et al.
Evaluation of Two rK39 Dipstick Tests, Direct Agglutination Test, and Indirect
Fluorescent Antibody Test for Diagnosis of Visceral Leishmaniasis in a New
Epidemic Site in Highland Ethiopia.
Am J Trop Med Hyg. 2011;84:102-106.
ABSTRACT available


5. SOONAWALA D, Geerts JW, de Mos M, Yazdanbakhsh M, et al.
The immune response to schistosome antigens in formerly infected travelers.
Am J Trop Med Hyg. 2011;84:43-7.
ABSTRACT available


6. AMARIR F, El Mansouri B, Fellah H, Sebti F, et al.
National serologic survey of haematobium schistosomiasis in morocco: evidence for
elimination.
Am J Trop Med Hyg. 2011;84:15-9.
ABSTRACT available


7. BANERJEE A, De M, Ali N.
Combination therapy with Paromomycin associated Stearylamine-bearing liposomes
cures experimental visceral leishmaniasis through Th1-biased immunomodulation.
Antimicrob Agents Chemother. 2011.
ABSTRACT available


8. LOISEAU PM, Gupta S, Verma A, Srivastava S, et al.
In Vitro Activity against Leishmania donovani of new 2-Substituted Quinolines.
Antimicrob Agents Chemother. 2011.
ABSTRACT available


9. MANNING L, Laman M, Stanisic D, Rosanas-Urgell A, et al.
Plasma Plasmodium falciparum Histidine-Rich Protein-2 Concentrations Do Not
Reflect Severity of Malaria in Papua New Guinean Children.
Clin Infect Dis. 2011.
ABSTRACT available


10. KAUR I, Schramm G, Everts B, Scholzen T, et al.
Interleukin-4 Inducing Principle from Schistosoma mansoni Eggs (IPSE/alpha-1)
contains a functional C-terminal nuclear localization signal necessary for
nuclear translocation in mammalian cells but not for its uptake.
Infect Immun. 2011.
ABSTRACT available


11. HOVSEPIAN E, Mirkin G, Penas F, Manzano A, et al.
Modulation of inflammatory response and parasitism by 15-Deoxy-Delta(12,14)
prostaglandin J(2) sin Trypanosoma cruzi-infected cardiomyocytes.
Int J Parasitol. 2011.
ABSTRACT available


12. CAMPO JJ, Aponte JJ, Nhabomba AJ, Sacarlal J, et al.
Feasibility of flow cytometry for measurements of P. falciparum parasite burden
in endemic malaria studies using bidimensional assessment of YOYO-1 and
autofluorescence.
J Clin Microbiol. 2011.
ABSTRACT available


13. KAPITO-TEMBO A, Meshnick SR, van Hensbroek MB, Phiri K, et al.
Marked Reduction in Prevalence of Malaria Parasitemia and Anemia in HIV-Infected
Pregnant Women Taking Cotrimoxazole With Or Without Sulfadoxine-Pyrimethamine
Intermittent Preventive Therapy during Pregnancy in Malawi.
J Infect Dis. 2011.
ABSTRACT available


14. INOUE M, Culleton RL.
The intradermal route for inoculation of sporozoites of rodent malaria parasites
for immunological studies.
Parasite Immunol. 2011;33:137-42.
ABSTRACT available


15. COURTIN D, Djilali-Saiah A, Milet J, Soulard V, et al.
Schistosoma haematobium infection affects Plasmodium falciparum-specific IgG
responses associated with protection against malaria.
Parasite Immunol. 2011;33:124-31.
ABSTRACT available


16. AWAH N, Balogun H, Achidi E, Mariuba LA, et al.
Antibodies to the Plasmodium falciparum rhoptry protein RAP-2/RSP-2 in relation
to anaemia in Cameroonian children.
Parasite Immunol. 2011;33:104-15.
ABSTRACT available


17. KAUR T, Sobti RC, Kaur S.
Cocktail of gp63 and Hsp70 induces protection against Leishmania donovani in
BALB/c mice.
Parasite Immunol. 2011;33:95-103.
ABSTRACT available


18. KRUDSOOD S, Looareesuwan S, Wilairatama P, Leowattana W, et al.
Effect of artesunate and mefloquine in combination on the Fridericia corrected QT
intervals in Plasmodium falciparum infected adults from Thailand.
Trop Med Int Health. 2011 Jan 10. doi: 10.1111/j.1365-3156.2010.02714.
ABSTRACT available


19. TOURE OA, Kouame MG, Didier YJ, Berenger AA, et al.
Artesunate/mefloquine paediatric formulation vs. artemether/lumefantrine for the
treatment of uncomplicated Plasmodium falciparum in Anonkoua koute, Cote
d'Ivoire.
Trop Med Int Health. 2011 Jan 9. doi: 10.1111/j.1365-3156.2010.02701.
ABSTRACT available


_____________________ ** End ** ______________________



We have screened the following journals for you:
Acta Cytol
Am J Gastroenterol
Am J Trop Med Hyg
Antimicrob Agents Chemother
Br J Dermatol
Br J Haematol
Clin Infect Dis
Epidemiol Infect
Eur J Immunol
Exp Parasitol
Infect Immun
Int J Parasitol
J Clin Microbiol
J Eukaryot Microbiol
J Exp Med
J Immunol
J Infect Dis
J Parasitol
JAMA
Lancet
N Engl J Med
Nat Med
Nature
Neurology
Parasite Immunol
Parasitology
Proc Natl Acad Sci U S A
Science
Trop Med Int Health

_________________________________________________________

Tuesday, December 21, 2010

Parasitic Diseases: Latest Research, 20th December 2010.


AMEDEO Parasitic Diseases


2010-12-20


________________ ** New articles **  _________________


1. PULLAN RL, Bukirwa H, Snow RW, Brooker S, et al.
Heritability of Plasmodium parasite density in a rural Ugandan community.
Am J Trop Med Hyg. 2010;83:990-5.
ABSTRACT available


2. MENENDEZ C, Serra-Casas E, Scahill MD, Sanz S, et al.
HIV and Placental Infection Modulate the Appearance of Drug-Resistant Plasmodium
falciparum in Pregnant Women who Receive Intermittent Preventive Treatment.
Clin Infect Dis. 2011;52:41-8.
ABSTRACT available


3. BEATTIE L, Phillips R, Brown N, Owens BM, et al.
IRF-7 contributes to the control of Leishmania donovani in the mouse liver.
Infect Immun. 2010.
ABSTRACT available


4. KURTIS JD, Higashi A, Wu HW, Gundogan F, et al.
Maternal schistosomiasis japonica is associated with maternal, placental and
fetal inflammation.
Infect Immun. 2010.
ABSTRACT available


5. LOPATICKI S, Maier AG, Thompson J, Wilson DW, et al.
Reticulocyte and erythrocyte binding-like proteins function cooperatively in
invasion of human erythrocytes by malaria parasites.
Infect Immun. 2010.
ABSTRACT available


6. HOU XY, Ellis MK, McManus DP, Wang YY, et al.
Diagnostic value of non-invasive biomarkers for stage-specific diagnosis of
hepatic fibrosis in patients with advanced schistosomiasis japonica.
Int J Parasitol. 2010.
ABSTRACT available


7. Proceedings of ICOPA (International Congress of Parasitology) XII. August 15-20,
2010. Melbourne, Australia.
Int J Parasitol. 2010;40:1107-228.



8. THOMPSON RC, Lymbery AJ, Smith A.
Parasites, emerging disease and wildlife conservation.
Int J Parasitol. 2010;40:1163-70.
ABSTRACT available


9. HOLT DC, McCarthy JS, Carapetis JR.
Parasitic diseases of remote Indigenous communities in Australia.
Int J Parasitol. 2010;40:1119-26.
ABSTRACT available


10. URSING J, Kofoed PE, Rodrigues A, Blessborn D, et al.
Similar Efficacy and Tolerability of Double-Dose Chloroquine and
Artemether-Lumefantrine for Treatment of Plasmodium falciparum Infection in
Guinea-Bissau: A Randomized Trial.
J Infect Dis. 2011;203:109-16.
ABSTRACT available


11. ROSYPAL AC, Tripp S, Lewis S, Francis J, et al.
Survey of Antibodies to Trypanosoma cruzi and Leishmania spp. in Gray and Red Fox
Populations From North Carolina and Virginia.
J Parasitol. 2010;96:1230-1.
ABSTRACT available


12. LEI SM, Romine NM, Beetham JK.
Population Changes in Leishmania chagasi Promastigote Developmental Stages Due to
Serial Passage.
J Parasitol. 2010;96:1134-8.
ABSTRACT available


13. HERNANDEZ-BELLO R, Escobedo G, Guzman C, Ibarra-Coronado EG, et al.
Immunoendocrine host-parasite interactions during helminth infections: from the
basic knowledge to its possible therapeutic applications.
Parasite Immunol. 2010;32.
ABSTRACT available


14. WEBSTER-KERR K, Peter Figueroa J, Weir PL, Lewis-Bell K, et al.
Success in controlling a major outbreak of malaria because of Plasmodium
falciparum in Jamaica.
Trop Med Int Health. 2010 Dec 10. doi: 10.1111/j.1365-3156.2010.02700.
ABSTRACT available


15. KAJAIA M, Morse DL, Kamkamidze G, Butsashvili M, et al.
Risk factors for relapse of visceral leishmaniasis in Georgia.
Trop Med Int Health. 2010 Dec 8. doi: 10.1111/j.1365-3156.2010.02694.
ABSTRACT available


_____________________ ** End ** ______________________



We have screened the following journals for you:
Acta Cytol
Am J Gastroenterol
Am J Trop Med Hyg
Antimicrob Agents Chemother
Br J Dermatol
Br J Haematol
Clin Infect Dis
Epidemiol Infect
Eur J Immunol
Exp Parasitol
Infect Immun
Int J Parasitol
J Clin Microbiol
J Eukaryot Microbiol
J Exp Med
J Immunol
J Infect Dis
J Parasitol
JAMA
Lancet
N Engl J Med
Nat Med
Nature
Neurology
Parasite Immunol
Parasitology
Proc Natl Acad Sci U S A
Science
Trop Med Int Health

_________________________________________________________

Sunday, December 12, 2010

Latest Malaria Research: Biochemical pathways of multi-drug resistance

Antimicrob Agents Chemother. 2010 Dec 6. [Epub ahead of print]

Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant clinical isolates of Plasmodium falciparum and P. vivax.

Marfurt J, Chalfein F, Prayoga P, Wabiser F, Kenangalem E, Piera KA, Fairlie DP, Tjitra E, Anstey NM, Andrews KT, Price RN.

Global Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Australia; Menzies School of Health Research-National Institute of Health Research and Development Malaria Research Program, Timika, Papua Indonesia; District Ministry of Health, Timika, Papua, Indonesia; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia; National Institute of Health Research and Development, Ministry of Health, Jakarta, Indonesia; Queensland Institute of Medical Research, Herston, Queensland, Australia; Centre for Tropical Medicine, Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford, UK.

Abstract

Histone acetylation plays an important role in regulating gene transcription and silencing in P. falciparum. Histone deacetylase (HDAC) inhibitors, particularly those of the hydroxamate class, have been shown to have potent in vitro activity against drug-resistant and sensitive laboratory strains of P. falciparum raising their potential as a new class of anti-malarial compounds. In the current study, stage-specific ex vivo susceptibility profiles of representative hydroxamate-based HDAC inhibitors SAHA, 2-ASA-9 and 2-ASA-14 were assessed in multidrug-resistant clinical isolates of P. falciparum (n=24) and P. vivax (n=25) from Papua, Indonesia, using a modified schizont maturation assay. Submicromolar concentrations of SAHA, 2-ASA-9 and 2-ASA-14 inhibited the growth of both P. falciparum (median IC50 310, 533 and 266 nM) and P. vivax (median IC50 170, 503, and 278 nM). Inverse correlation patterns between HDAC inhibitors and chloroquine for P. falciparum and mefloquine for P. vivax indicate species-specific susceptibility profiles for HDAC inhibitors. These HDAC inhibitors were also found to be potent ex vivo against P. vivax schizont maturation, comparable to that in P. falciparum, suggesting that HDAC inhibitors may be promising candidates for anti-malarial therapy in geographical locations where both species are endemic. Further studies optimizing the selectivity and in vivo efficacy of HDAC inhibitors in Plasmodium and defining drug interaction with common anti-malarial compounds are warranted to investigate the role of HDAC inhibitors in anti-malarial therapy.
PMID: 21135175 [PubMed - as supplied by publisher]

"Artemisone uptake in Plasmodium falciparum-infected erythrocytes."

Antimicrob Agents Chemother. 2010 Dec 6. [Epub ahead of print]

Artemisone uptake in Plasmodium falciparum-infected erythrocytes.
Pooley S, Fatih F, Krishna S, Gerisch M, Haynes RK, Wong HN, Staines HM.

Centre for Infection, Division of Cellular and Molecular Medicine, St. George's, University of London, Cranmer Terrace, London SW17 0RE, Great Britain; Bayer Schering Pharma AG, DMPK, 42096 Wuppertal, Germany; and Department of Chemistry, Open Laboratory of Chemical Biology, Institute of Molecular Technology for Drug Discovery and Synthesis, The Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong (PR China).

Abstract

Artemisone is one of the most promising artemisinin derivatives in clinical trials. Previous studies with radiolabelled artemisinin and dihydroartemisinin have measured uptake in P. falciparum-infected erythrocytes. Uptake is much greater in infected compared with uninfected erythrocytes but the relative contributions of transport, binding and metabolism to this process still await definition. In this study, we characterised mechanisms by which [(14)C] artemisone in taken up into uninfected and P. falciparum-infected human erythrocytes in vitro. Radiolabelled artemisone rapidly enters uninfected erythrocytes without much exceeding extracellular concentrations. Unlabelled artemisone does not compete in this process. Radiolabelled artemisone is concentrated greatly by a time- and temperature-dependent mechanism in infected erythrocytes. This uptake is abrogated by unlabelled artemisone. In addition, the uptake of artemisone into three subcellular fractions, and its distribution into these fractions, is examined as a function of parasite maturation. These data are relevant to understanding the mechanisms of action of this important class of drug.
PMID: 21135191 [PubMed - as supplied by publisher]

Research Summary: Parasitic Diseases - December 2010

AMEDEO Parasitic Diseases
http://www.amedeo.com

2010-12-13


________________ ** New articles **  _________________


1. POOLEY S, Fatih F, Krishna S, Gerisch M, et al.
Artemisone uptake in Plasmodium falciparum-infected erythrocytes.
Antimicrob Agents Chemother. 2010.
http://amedeo.com/p2.php?id=21135191&s=pad&pm=0da2afd4a82ab52
ABSTRACT available


2. MARFURT J, Chalfein F, Prayoga P, Wabiser F, et al.
Ex vivo activity of histone deacetylase inhibitors against multidrug-resistant
clinical isolates of Plasmodium falciparum and P. vivax.
Antimicrob Agents Chemother. 2010.
http://amedeo.com/p2.php?id=21135175&s=pad&pm=0da2afd4a82ab52
ABSTRACT available


3. KAR S, Ukil A, Das PK.
Cystatin cures visceral leishmaniasis by NF-kappaB-mediated proinflammatory
response through co-ordination of TLR/MyD88 signaling with p105-Tpl2-ERK pathway.
Eur J Immunol. 2010.
http://amedeo.com/p2.php?id=21132711&s=pad&pm=0da2afd4a82ab52
ABSTRACT available


4. POPP M, Lattorff HM.
A Quantitative In Vitro Cultivation Technique to Determine Cell Number and Growth
Rates in Strains of Crithidia bombi (Trypanosomatidae), a Parasite of Bumblebees.
J Eukaryot Microbiol. 2010 Dec 3. doi: 10.1111/j.1550-7408.2010.00514.
http://amedeo.com/p2.php?id=21129082&s=pad&pm=0da2afd4a82ab52
ABSTRACT available


_____________________ ** End ** ______________________



We have screened the following journals for you:
Acta Cytol
Am J Gastroenterol
Am J Trop Med Hyg
Antimicrob Agents Chemother
Br J Dermatol
Br J Haematol
Clin Infect Dis
Epidemiol Infect
Eur J Immunol
Exp Parasitol
Infect Immun
Int J Parasitol
J Clin Microbiol
J Eukaryot Microbiol
J Exp Med
J Immunol
J Infect Dis
J Parasitol
JAMA
Lancet
N Engl J Med
Nat Med
Nature
Neurology
Parasite Immunol
Parasitology
Proc Natl Acad Sci U S A
Science
Trop Med Int Health

_________________________________________________________

Sunday, December 5, 2010

Parasitic Diseases: Latest Research, December 2010.


1. AMEDEO Parasitic Diseases

2010-12-06 

________________ ** New articles **  _________________


1. LAMBERTON PH, Hogan SC, Kabatereine NB, Fenwick A, et al.
In Vitro Praziquantel Test Capable of Detecting Reduced In Vivo Efficacy in Schistosoma mansoni Human Infections.
Am J Trop Med Hyg. 2010;83:1340-7.
ABSTRACT available


2. VAN THIEL PP, Leenstra T, de Vries HJ, van der Sluis A, et al.
Cutaneous Leishmaniasis (Leishmania major Infection) in Dutch Troops Deployed in Northern Afghanistan: Epidemiology, Clinical Aspects, and Treatment.
Am J Trop Med Hyg. 2010;83:1295-1300.
ABSTRACT available


3. TODOLI F, Solano-Gallego L, de Juan R, Morell P, et al.
Humoral and In Vivo Cellular Immunity against the Raw Insect-Derived Recombinant Leishmania infantum Antigens KMPII, TRYP, LACK, and papLe22 in Dogs from an Endemic Area.
Am J Trop Med Hyg. 2010;83:1287-1294.
ABSTRACT available


4. MAYXAY M, Keomany S, Khanthavong M, Souvannasing P, et al.
A Phase III, Randomized, Non-Inferiority Trial to Assess the Efficacy and Safety of Dihydroartemisinin-Piperaquine in Comparison with Artesunate-Mefloquine in Patients with Uncomplicated Plasmodium falciparum Malaria in Southern Laos.
Am J Trop Med Hyg. 2010;83:1221-1229.
ABSTRACT available


5. BOUNKEUA V, Li F, Vinetz JM.
In Vitro Generation of Plasmodium falciparum Ookinetes.
Am J Trop Med Hyg. 2010;83:1187-94.
ABSTRACT available


6. KAUR J, Kumar P, Tyagi S, Pathak R, et al.
An in silico screening, structure-activity relationship and biologic evaluation
of selective pteridine reductase inhibitors targeting visceral leishmaniasis.
Antimicrob Agents Chemother. 2010.
ABSTRACT available


7. VIEIRA DP, da Silva RP, Saraiva EM, Lopes AH, et al.
Leishmania chagasi: An ecto- 3'-nucleotidase activity modulated by inorganic
phosphate and its possible involvement in parasite-macrophage interaction.
Exp Parasitol. 2010.
ABSTRACT available


8. MALAFAIA G, de Nadai Marcon L, de Fatima Pereira L, Pedrosa ML, et al.
Leishmania chagasi: effect of the iron deficiency on the infection in BALB/c
mice.
Exp Parasitol. 2010.
ABSTRACT available


9. COELHO-FINAMORE JM, Freitas VC, Assis RR, Melo MN, et al.
Leishmania infantum: Lipophosphoglycan intraspecific variation and interaction
with vertebrate and invertebrate hosts.
Int J Parasitol. 2010.
ABSTRACT available


10. NAKAZAWA S, Culleton R, Maeno Y.
In vivo and in vitro gametocyte production of Plasmodium falciparum isolates from
Northern Thailand.
Int J Parasitol. 2010.
ABSTRACT available


11. SILVA JC, Egan A, Friedman R, Munro JB, et al.
Genome sequences reveal divergence times of malaria parasite lineages.
Parasitology. 2010.
ABSTRACT available


_____________________ ** End ** ______________________



We have screened the following journals for you:
Acta Cytol
Am J Gastroenterol
Am J Trop Med Hyg
Antimicrob Agents Chemother
Br J Dermatol
Br J Haematol
Clin Infect Dis
Epidemiol Infect
Eur J Immunol
Exp Parasitol
Infect Immun
Int J Parasitol
J Clin Microbiol
J Eukaryot Microbiol
J Exp Med
J Immunol
J Infect Dis
J Parasitol
JAMA
Lancet
N Engl J Med
Nat Med
Nature
Neurology
Parasite Immunol
Parasitology
Proc Natl Acad Sci U S A
Science
Trop Med Int Health

_________________________________________________________

Saturday, November 27, 2010

Parasitic Diseases: Latest Research, November 2010.

1. AMEDEO Parasitic Diseases

2010-11-29


________________ ** New articles **  _________________


1. ASAHI H, Izumiyama S, Tolba ME, Kwansa-Bentum B, et al.
Plasmodium falciparum: Differing effects of nonesterified fatty acids and phospholipids on intraerythrocytic growth in serum-free medium.
Exp Parasitol. 2010.
ABSTRACT available


2. WERE T, Davenport GC, Hittner JB, Ouma C, et al.
Bacteremia in Kenyan Children with Malaria Presenting at a Rural Hospital in a Holoendemic Plasmodium falciparum Transmission Area.
J Clin Microbiol. 2010.
ABSTRACT available


3. FARIA MS, Reis FC, Azevedo-Pereira RL, Morrison LS, et al.
Leishmania Inhibitor of Serine Peptidase 2 Prevents TLR4 Activation by Neutrophil Elastase Promoting Parasite Survival in Murine Macrophages.
J Immunol. 2010.
ABSTRACT available


4. TUON FF, Fernandes ER, Pagliari C, Duarte MI, et al.
The expression of TLR9 in human cutaneous leishmaniasis is associated with granuloma.
Parasite Immunol. 2010;32.
ABSTRACT available


5. SCHRODER WA, Gardner J, Le TT, Duke M, et al.
SerpinB2 deficiency modulates Th1Th2 responses after schistosome infection.
Parasite Immunol. 2010;32.
ABSTRACT available


_____________________ ** End ** ______________________



We have screened the following journals for you:
Acta Cytol
Am J Gastroenterol
Am J Trop Med Hyg
Antimicrob Agents Chemother
Br J Dermatol
Br J Haematol
Clin Infect Dis
Epidemiol Infect
Eur J Immunol
Exp Parasitol
Infect Immun
Int J Parasitol
J Clin Microbiol
J Eukaryot Microbiol
J Exp Med
J Immunol
J Infect Dis
J Parasitol
JAMA
Lancet
N Engl J Med
Nat Med
Nature
Neurology
Parasite Immunol
Parasitology
Proc Natl Acad Sci U S A
Science
Trop Med Int Health

_________________________________________________________